116 related articles for article (PubMed ID: 32520634)
1. The landscape of gene mutations and clinical significance of tumor mutation burden in patients with soft tissue sarcoma who underwent surgical resection and received conventional adjuvant therapy.
Xu LB; Zhao ZG; Xu SF; Zhang XX; Liu T; Jing CY; Zhang SG; Yu SJ
Int J Biol Markers; 2020 Sep; 35(3):14-22. PubMed ID: 32520634
[TBL] [Abstract][Full Text] [Related]
2. Prognostic Significance of Tumor Mutation Burden among Patients with Non-small Cell Lung Cancer Who Received Platinum-based Adjuvant Chemotherapy: An Exploratory Study.
Shen WX; Li GH; Li YJ; Zhang PF; Yu JX; Shang D; Wang QS
J Cancer Prev; 2023 Dec; 28(4):175-184. PubMed ID: 38205359
[TBL] [Abstract][Full Text] [Related]
3. Tumor mutation burden and checkpoint immunotherapy markers in primary and metastatic synovial sarcoma.
He M; Abro B; Kaushal M; Chen L; Chen T; Gondim M; Yan W; Neidich J; Dehner LP; Pfeifer JD
Hum Pathol; 2020 Jun; 100():15-23. PubMed ID: 32387103
[TBL] [Abstract][Full Text] [Related]
4. Molecular landscape and therapeutic alterations in Asian soft-tissue sarcoma patients.
Gan M; Zhang C; Qiu L; Wang Y; Bao H; Yu R; Liu R; Wu X; Shao Y; Hou P; Fei Z
Cancer Med; 2022 Nov; 11(21):4070-4078. PubMed ID: 35586877
[TBL] [Abstract][Full Text] [Related]
5. Tumor Mutation Burden and Prognosis in Patients with Colorectal Cancer Treated with Adjuvant Fluoropyrimidine and Oxaliplatin.
Lee DW; Han SW; Bae JM; Jang H; Han H; Kim H; Bang D; Jeong SY; Park KJ; Kang GH; Kim TY
Clin Cancer Res; 2019 Oct; 25(20):6141-6147. PubMed ID: 31285374
[TBL] [Abstract][Full Text] [Related]
6. Trends in the Use of Adjuvant Chemotherapy for High-Grade Truncal and Extremity Soft Tissue Sarcomas.
Squires MH; Ethun CG; Suarez-Kelly LP; Yu PY; Hughes TM; Shelby RD; Tran TB; Poultsides G; Charlson J; Gamblin TC; Tseng J; Roggin KK; Chouliaras K; Votanopoulos K; Krasnick BA; Fields RC; Pollock RE; Grignol V; Cardona K; Howard JH
J Surg Res; 2020 Jan; 245():577-586. PubMed ID: 31494391
[TBL] [Abstract][Full Text] [Related]
7. Comprehensive genomic analysis of primary bone sarcomas reveals different genetic patterns compared with soft tissue sarcomas.
Zhang Q; Yang Y; You X; Ju Y; Zhang Q; Sun T; Liu W
Front Oncol; 2023; 13():1173275. PubMed ID: 37546405
[TBL] [Abstract][Full Text] [Related]
8. Prognostic attributes of immune signatures in soft tissue sarcomas show differential dependencies on tumor mutational burden.
Raj SKS; Routh ED; Chou JW; Votanopoulos KI; Triozzi PL; Miller LD
Cancer; 2022 Sep; 128(17):3254-3264. PubMed ID: 35767280
[TBL] [Abstract][Full Text] [Related]
9. The clinical utility of next-generation sequencing for bone and soft tissue sarcoma.
Gusho CA; Weiss MC; Lee L; Gitelis S; Blank AT; Wang D; Batus M
Acta Oncol; 2022 Jan; 61(1):38-44. PubMed ID: 34686105
[No Abstract] [Full Text] [Related]
10. SPARC expression in patients with high-risk localized soft tissue sarcoma treated on a randomized phase II trial of neo/adjuvant chemotherapy.
Davis EJ; Zhao L; Lucas DR; Schuetze SM; Baker LH; Zalupski MM; Thomas D; Chugh R
BMC Cancer; 2016 Aug; 16():663. PubMed ID: 27544129
[TBL] [Abstract][Full Text] [Related]
11. Tumor mutational burden and driver mutations: Characterizing the genomic landscape of pediatric brain tumors.
Patel RR; Ramkissoon SH; Ross J; Weintraub L
Pediatr Blood Cancer; 2020 Jul; 67(7):e28338. PubMed ID: 32386112
[TBL] [Abstract][Full Text] [Related]
12. Prognostic factors in adolescents and young adults (AYA) with high risk soft tissue sarcoma (STS) treated by adjuvant chemotherapy: a study based on pooled European Organisation for Research and Treatment of Cancer (EORTC) clinical trials 62771 and 62931.
Kasper B; Ouali M; van Glabbeke M; Blay JY; Bramwell VH; Woll PJ; Hohenberger P; Schöffski P
Eur J Cancer; 2013 Jan; 49(2):449-56. PubMed ID: 22975215
[TBL] [Abstract][Full Text] [Related]
13. Prognostic factors in adult patients with locally controlled soft tissue sarcoma. A study of 546 patients from the French Federation of Cancer Centers Sarcoma Group.
Coindre JM; Terrier P; Bui NB; Bonichon F; Collin F; Le Doussal V; Mandard AM; Vilain MO; Jacquemier J; Duplay H; Sastre X; Barlier C; Henry-Amar M; Macé-Lesech J; Contesso G
J Clin Oncol; 1996 Mar; 14(3):869-77. PubMed ID: 8622035
[TBL] [Abstract][Full Text] [Related]
14. Does adjuvant radiation therapy increase loco-regional control after optimal resection of soft-tissue sarcoma of the extremities?
Khanfir K; Alzieu L; Terrier P; Le Péchoux C; Bonvalot S; Vanel D; Le Cesne A
Eur J Cancer; 2003 Sep; 39(13):1872-80. PubMed ID: 12932665
[TBL] [Abstract][Full Text] [Related]
15. Prognostic value of external beam radiation therapy in patients treated with surgical resection and intraoperative electron beam radiation therapy for locally recurrent soft tissue sarcoma: a multicentric long-term outcome analysis.
Calvo FA; Sole CV; Cambeiro M; Montero A; Polo A; Gonzalez C; Cuervo M; San Julian M; Garcia-Sabrido JL; Martinez-Monge R
Int J Radiat Oncol Biol Phys; 2014 Jan; 88(1):143-50. PubMed ID: 24331661
[TBL] [Abstract][Full Text] [Related]
16. Sequencing radiotherapy for soft tissue sarcoma when re-resection is planned.
Zagars GK; Ballo MT
Int J Radiat Oncol Biol Phys; 2003 May; 56(1):21-7. PubMed ID: 12694820
[TBL] [Abstract][Full Text] [Related]
17. Integrative profiling analysis reveals prognostic significance, molecular characteristics, and tumor immunity of angiogenesis-related genes in soft tissue sarcoma.
Liu B; Li C; Feng C; Wang H; Zhang H; Tu C; He S; Li Z
Front Immunol; 2023; 14():1178436. PubMed ID: 37377953
[TBL] [Abstract][Full Text] [Related]
18. Doxorubicin-based adjuvant chemotherapy in soft tissue sarcoma: pooled analysis of two STBSG-EORTC phase III clinical trials.
Le Cesne A; Ouali M; Leahy MG; Santoro A; Hoekstra HJ; Hohenberger P; Van Coevorden F; Rutkowski P; Van Hoesel R; Verweij J; Bonvalot S; Steward WP; Gronchi A; Hogendoorn PCW; Litiere S; Marreaud S; Blay JY; Van Der Graaf WTA
Ann Oncol; 2014 Dec; 25(12):2425-2432. PubMed ID: 25294887
[TBL] [Abstract][Full Text] [Related]
19. High tumor mutation burden indicates better prognosis in colorectal cancer patients with
Wang J; Song J; Liu Z; Zhang T; Liu Y
Front Oncol; 2022; 12():1015308. PubMed ID: 36452508
[TBL] [Abstract][Full Text] [Related]
20. Treatment of soft tissue sarcoma in childhood and adolescence. A report of the German Cooperative Soft Tissue Sarcoma Study.
Koscielniak E; Jürgens H; Winkler K; Bürger D; Herbst M; Keim M; Bernhard G; Treuner J
Cancer; 1992 Nov; 70(10):2557-67. PubMed ID: 1482503
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
